Interventions to treat premature ejaculation: a systematic review short report
- PMID: 25768099
- PMCID: PMC4781071
- DOI: 10.3310/hta19210
Interventions to treat premature ejaculation: a systematic review short report
Abstract
Background: Premature ejaculation (PE) is commonly defined as ejaculation with minimal sexual stimulation before, on or shortly after penetration and before the person wishes it. PE can be either lifelong and present since first sexual experiences (primary), or acquired (secondary), beginning later (Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther 1989;15:130-4). Treatments include behavioural and pharmacological interventions.
Objective: To systematically review evidence for clinical effectiveness of behavioural, topical and systemic treatments for PE.
Data sources: The following databases were searched from inception to 6 August 2013 for published and unpublished research evidence: MEDLINE; EMBASE; Cumulative Index to Nursing and Allied Health Literature; The Cochrane Library including the Cochrane Systematic Reviews Database, Cochrane Controlled Trials Register, Database of Abstracts of Reviews of Effects and the Health Technology Assessment database; ISI Web of Science, including Science Citation Index, and the Conference Proceedings Citation Index-Science. The US Food and Drug Administration website and the European Medicines Agency (EMA) website were also searched.
Methods: Randomised controlled trials (RCTs) in adult men with PE were eligible (or non-RCTs in the absence of RCTs). RCT data were extrapolated from review articles when available. The primary outcome was intravaginal ejaculatory latency time (IELT). Data were meta-analysed when possible. Other outcomes included sexual satisfaction, control over ejaculation, relationship satisfaction, self-esteem, quality of life, treatment acceptability and adverse events (AEs).
Results: A total of 103 studies (102 RCTs, 65 from reviews) were included. RCTs were available for all interventions except yoga. The following interventions demonstrated significant improvements (p < 0.05) in arithmetic mean difference in IELT compared with placebo: topical anaesthetics - eutectic mixture of local anaesthetics (EMLA(®), AstraZeneca), topical eutectic mixture for PE (Plethora Solutions Ltd) spray; selective serotonin reuptake inhibitors (SSRIs) - citalopram (Cipramil(®), Lundbeck), escitalopram (Cipralex(®), Lundbeck), fluoxetine, paroxetine, sertraline, dapoxetine (Priligy(®), Menarini), 30 mg or 60 mg; serotonin-noradrenaline reuptake inhibitors - duloxetine (Cymbalta(®), Eli Lilly & Co Ltd); tricyclic antidepressants - inhaled clomipramine 4 mg; phosphodiesterase-5 (PDE5) inhibitors - vardenafil (Levitra(®), Bayer), tadalafil (Cialis(®), Eli Lilly & Co Ltd); opioid analgesics - tramadol (Zydol SR(®), Grünenthal). Improvements in sexual satisfaction and other outcomes compared with placebo were evident for SSRIs, PDE5 inhibitors and tramadol. Outcomes for interventions not compared with placebo were as follows: behavioural therapies - improvements over wait list control in IELT and other outcomes, behavioural therapy plus pharmacotherapy better than either therapy alone; alpha blockers - terazosin (Hytrin(®), AMCO) not significantly different to antidepressants in ejaculation control; acupuncture - improvements over sham acupuncture in IELT, conflicting results for comparisons with SSRIs; Chinese medicine - improvements over treatment as usual; delay device - improvements in IELT when added to stop-start technique; yoga - improved IELT over baseline, fluoxetine better than yoga. Treatment-related AEs were evident with most pharmacological interventions.
Limitations: Although data extraction from reviews was optimised when more than one review reported data for the same RCT, the reliability of the data extraction within these reviews cannot be guaranteed by this assessment report.
Conclusions: Several interventions significantly improved IELT. Many interventions also improved sexual satisfaction and other outcomes. However, assessment of longer-term safety and effectiveness is required to evaluate whether or not initial treatment effects are maintained long term, whether or not dose escalation is required, how soon treatment effects end following treatment cessation and whether or not treatments can be stopped and resumed at a later time. In addition, assessment of the AEs associated with long-term treatment and whether or not different doses have differing AE profiles is required.
Study registration: This study is registered as PROSPERO CRD42013005289.
Funding: The National Institute for Health Research Health Technology Assessment programme.
Similar articles
-
Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis.Eur Urol Focus. 2017 Feb;3(1):119-129. doi: 10.1016/j.euf.2016.02.001. Epub 2016 Feb 19. Eur Urol Focus. 2017. PMID: 28720356 Free PMC article.
-
Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis.Eur Urol. 2016 May;69(5):904-16. doi: 10.1016/j.eururo.2015.12.028. Epub 2015 Dec 31. Eur Urol. 2016. PMID: 26749092 Review.
-
Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials.Int J Impot Res. 2018 Oct;30(5):215-223. doi: 10.1038/s41443-018-0030-x. Epub 2018 Jun 20. Int J Impot Res. 2018. PMID: 29921893
-
Psychosocial interventions for premature ejaculation.Cochrane Database Syst Rev. 2011 Aug 10;(8):CD008195. doi: 10.1002/14651858.CD008195.pub2. Cochrane Database Syst Rev. 2011. PMID: 21833964 Review.
-
Selective dorsal neurotomy in the treatment of premature ejaculation: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Aug 21;99(34):e21866. doi: 10.1097/MD.0000000000021866. Medicine (Baltimore). 2020. PMID: 32846840 Free PMC article.
Cited by
-
Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.Cochrane Database Syst Rev. 2021 Mar 21;3(3):CD012799. doi: 10.1002/14651858.CD012799.pub2. Cochrane Database Syst Rev. 2021. PMID: 33745183 Free PMC article.
-
Safety and efficacy of "on-demand" tramadol in patients with premature ejaculation: an updated meta-analysis.Int Braz J Urol. 2021 Sep-Oct;47(5):921-934. doi: 10.1590/S1677-5538.IBJU.2020.0561. Int Braz J Urol. 2021. PMID: 33566469 Free PMC article. Review.
-
Vibrator-Assisted Start-Stop Exercises Improve Premature Ejaculation Symptoms: A Randomized Controlled Trial.Arch Sex Behav. 2020 Jul;49(5):1559-1573. doi: 10.1007/s10508-019-01520-0. Epub 2019 Nov 18. Arch Sex Behav. 2020. PMID: 31741252 Free PMC article. Clinical Trial.
-
Interventions to Treat Erectile Dysfunction and Premature Ejaculation: An Overview of Systematic Reviews.Sex Med. 2019 Sep;7(3):251-269. doi: 10.1016/j.esxm.2019.06.001. Epub 2019 Jul 9. Sex Med. 2019. PMID: 31300388 Free PMC article. Review.
-
Efficacy and safety of sertraline for the treatment of premature ejaculation: Systematic review and meta-analysis.Medicine (Baltimore). 2019 Jun;98(23):e15989. doi: 10.1097/MD.0000000000015989. Medicine (Baltimore). 2019. PMID: 31169738 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials